NCT07428616Phase 2Recruiting

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

Study sponsor: Exelixis

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2028-02-29Estimated
Enrollment · participants100Estimated
Source updated2026-10-28Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source

· 1 field changed

Primary completion date changed

Before: Feb 2028. After: 29 Feb 2028.

Check registry source